ARID1A Regulates Progesterone Receptor Expression in Endometrial Carcinoma and xAtypical Hyperplasia

被引：0
作者：
Liu, Ying [1 ]
Asaka, Shiho [2 ]
Wang, Tian-Li [1 ]
Shih, Ie-Ming [3 ]
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Shinshu Univ, Sch Med, Matsumoto, Nagano, Japan
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
MODERN PATHOLOGY | 2022年 / 35卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
733
引用
收藏
页码：790 / 790
页数：1
相关论文
共 50 条
[21]   Histopathologic Correlation with ARID1A Immunohistochemistry in Endometrial Carcinomas, Including Description of Subclonal ARID1A Loss [J].
Xiong, Jessie ;
Smith, Lynelle ;
Black, Margaret ;
Wolsky, Rebecca ;
Post, Miriam .
LABORATORY INVESTIGATION, 2024, 104 (03) :S1270-S1271
[22]   Estrogen-α and progesterone receptor expression in cystic endometrial hyperplasia and pyometra in the bitch [J].
De Bosschere, H ;
Ducatelle, R ;
Vermeirsch, H ;
Simoens, P ;
Coryn, M .
ANIMAL REPRODUCTION SCIENCE, 2002, 70 (3-4) :251-259
[23]   CRISPR/Cas9-Mediated Gene Knockout of ARID1A Promotes Primary Progesterone Resistance by Downregulating Progesterone Receptor B in Endometrial Cancer Cells [J].
Wang, Haizhen ;
Tang, Zhenghua ;
Li, Ting ;
Liu, Menglu ;
Li, Yong ;
Xing, Baoling .
ONCOLOGY RESEARCH, 2019, 27 (09) :1051-1060
[24]   Diagnostic Importance of PAX2, ARID1A, and FOXA1 Biomarkers in Atypical Endometrial Hyperplasia [J].
Yildiz, Ozlem Nur ;
Topal, Cumhur Selcuk ;
Zemheri, Itir Ebru .
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (08) :847-851
[25]   ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component [J].
Nishikimi, Kyoko ;
Kiyokawa, Takako ;
Tate, Shinichi ;
Iwamoto, Masami ;
Shozu, Makio .
HISTOPATHOLOGY, 2015, 67 (06) :866-871
[26]   ANALYSIS OF PTEN, ESTROGEN RECEPTOR α AND PROGESTERONE RECEPTOR EXPRESSION IN ENDOMETRIAL HYPERPLASIA USING TISSUE MICROARRAY [J].
Pieczynska, Beata ;
Wojtylak, Szymon ;
Zawrocki, Anton ;
Biernat, Wojciech .
POLISH JOURNAL OF PATHOLOGY, 2011, 62 (03) :133-138
[27]   Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications [J].
Fadare, O. ;
Renshaw, I. L. ;
Liang, S. X. .
LABORATORY INVESTIGATION, 2012, 92 :269A-269A
[28]   Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications [J].
Fadare, O. ;
Renshaw, I. L. ;
Liang, S. X. .
MODERN PATHOLOGY, 2012, 25 :269A-269A
[29]   ARID1A: gene, protein, and function in endometrial cancer [J].
LaBuda, Savannah E. ;
Broaddus, Russell R. ;
Gladden, Andrew B. .
ONCOGENE, 2025, :3273-3283
[30]   ARID1A Suppresses Proliferative Signaling Driven by Estrogen Receptor alpha in Endometrial Cancer [J].
Polaski, Jacob T. ;
Crockett, Isabella G. ;
Rush, Craig M. ;
Kitchen, Noel ;
Vahrenkamp, Jeffery M. ;
Nevarez, Brianna ;
Gertz, Jay .
ENDOCRINOLOGY, 2025, 166 :A2-A3
12345